Magnesium deficiency and Mitral Valve Prolapse

Zeana, C. D. (1988). “Recent data on mitral valve prolapse and magnesium deficit.” Magnes Res 1(3-4): 203-11., W., A. Nowak, et al. (2005). “The importance of magnesium status in the pathophysiology of mitral valve prolapse.” Magnes Res 18(1): 35-52., W., A. Siwinska, et al. (2001). “[Electrolyte abnormalities and ventricular arrhythmias in children with mitral valve prolapse].” Pol Merkuriusz Lek 11(62): 125-8.

Braun, W. E., J. Ronan, et al. (1977). “HLA antigens in mitral valve prolapse.” Transplant Proc 9(4): 1869-71.

Coghlan, H. C. and G. Natello (1991). “Erythrocyte magnesium in symptomatic patients with primary mitral valve prolapse: relationship to symptoms, mitral leaflet thickness, joint hypermobility and autonomic regulation.” Magnes Trace Elem 10(2-4): 205-14.

Cohen, L., H. Bitterman, et al. (1986). “Idiopathic magnesium deficiency in mitral valve prolapse.” Am J Cardiol 57(6): 486-7.

Cohen, L., A. Laor, et al. (1988). “Renal excretion of lactate and magnesium in mitral valve prolapse.” Magnes Res 1(1-2): 75-8.

Devereux, R. B., E. C. Jones, et al. (2001). “Prevalence and correlates of mitral valve prolapse in a population-based sample of American Indians: the Strong Heart Study.” Am J Med 111(9): 679-85.

Disse, S., E. Abergel, et al. (1999). “Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1.” Am J Hum Genet 65(5): 1242-51.

Durlach, J. (1994). “Primary mitral valve prolapse: a clinical form of primary magnesium deficit.” Magnes Res 7(3-4): 339-40.

Durlach, J., P. Bac, et al. (1997). “Neurotic, neuromuscular and autonomic nervous form of magnesium imbalance.” Magnes Res 10(2): 169-95.

Durlach, J. and V. Durlach (1986). “Idiopathic mitral valve prolapse and magnesium:  state of the art.” Magnesium Bul 8: 156-169
Durlach, J., V. Durlach, et al. (1992). “Magnesium and blood pressure. II. Clinical studies.” Magnes Res 5(2): 147-53.

Durlach, J., G. Lutfalla, et al. (1985). Latent tetany and mitral valve prolapse due to chronic primary magnesium  deficit. Magnesium Deficiency Physiopathology and Treatment Implications. H. M. J. D. J. Basel, Switzerland, Karger102-112

Fauchier, J. P., D. Babuty, et al. (2000). “[Mitral valve prolapse, arrhythmias and sudden death].” Arch Mal Coeur Vaiss 93(12): 1541-7.

Frances, Y., F. Collet, et al. (1986). “Long-term follow-up of mitral valve prolapse and latent tetany. Preliminary data.” Magnesium 5(3-4): 175-81.

Galland, L. (1985). Magnesium deficiency in mitral valve prolapse. Magnesium Deficiency Physiopathology and Treatment Implications. M. J. Halpern and J. Durlach. Basel, Switzerland, Karger117-119

Galland, L. D., S. M. Baker, et al. (1986). “Magnesium deficiency in the pathogenesis of mitral valve prolapse.” Magnesium 5(3-4): 165-74.

Gerard, R., R. Luccioni, et al. (1979). “[Mitral valve prolapse and spasmophilia in the adult].” Arch Mal Coeur Vaiss 72(7): 715-20.

Kachru, R. B., M. Telischi, et al. (1979). “The HLA antigens and ABO blood groups in an American Black population with mitral valve prolapse.” Tissue Antigens 14(3): 256-60.

Kitlinski, M., E. Konduracka, et al. (2000). “[Evaluation of magnesium cation levels in serum of patients with mitral valve prolapse syndrome].” Folia Med Cracov 41(3-4): 17-24.

Klos, J., B. Lichodziejewska, et al. (1988). “[Results of the compensatory treatment of disorders of magnesium and calcium metabolism in mitral valve prolapse syndrome].” Pol Tyg Lek 43(41): 1330-3.

Klos, J., B. Lichodziejewska, et al. (1988). “[Disorders of magnesium and calcium metabolism in mitral valve prolapse syndrome].” Pol Tyg Lek 43(41): 1325-9.

Lichodziejewska, B., J. Klos, et al. (1997). “Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation.” Am J Cardiol 79(6): 768-72.

Martynov, A. I., O. B. Stepura, et al. (2000). “[New approaches to the treatment of patients with idiopathic mitral valve prolapse].” Ter Arkh 72(9): 67-70.

Simoes Fernandes, J., T. Pereira, et al. (1985). “Therapeutic effect of a magnesium salt in patients suffering from mitral valvular prolapse and latent tetany.” Magnesium 4(5-  6): 283-90.

Zeana, C., M. Briciu, et al. (1985). “Considerations on the pathogenesis of mitral valve prolapse.” Med Interne 23(3): 165-70.   cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=4048797